Lexaria Bioscience Corp. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lexaria Bioscience Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Lexaria Bioscience Corp. Operating Income (Loss) for the quarter ending May 31, 2024 was -$1.74M, a 27.4% increase year-over-year.
  • Lexaria Bioscience Corp. Operating Income (Loss) for the twelve months ending May 31, 2024 was -$4.66M.
  • Lexaria Bioscience Corp. annual Operating Income (Loss) for 2023 was -$6.53M, a 1.28% increase from 2022.
  • Lexaria Bioscience Corp. annual Operating Income (Loss) for 2022 was -$6.62M, a 16.4% decline from 2021.
  • Lexaria Bioscience Corp. annual Operating Income (Loss) for 2021 was -$5.69M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6.53M +$85K +1.28% Sep 1, 2022 Aug 31, 2023 10-K 2023-11-20
2022 -$6.62M -$932K -16.4% Sep 1, 2021 Aug 31, 2022 10-K 2023-11-20
2021 -$5.69M Sep 1, 2020 Aug 31, 2021 10-K 2022-11-28
2016 -$1.28M +$706K +35.6% Sep 1, 2015 Aug 31, 2016 10-K 2016-11-29
2015 -$1.98M -$424K -27.2% Sep 1, 2014 Aug 31, 2015 10-K 2016-11-29
2014 -$1.56M Sep 1, 2013 Aug 31, 2014 10-K 2015-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.